FACT II Acquisition
FACTW · NASDAQ
FACTW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.19K
- Volume
- 120
- Open price
- $0.1803
- High today
- $0.1803
- Low today
- $0.1803
- 52 Week high
- $0.8798
- 52 Week low
- $0.105
FACT II Acquisition (FACTW) at a glance
FACT II Acquisition (FACTW) last traded at $0.1803, with a price-to-earnings ratio of 0.00.
Volume so far is 120 shares, below the average of 1.19K shares a day.
Over the past year FACT II Acquisition has ranged from $0.105 to $0.8798, and now sits 10% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- RDARRaadr$0.0002+20.00%
- RCTRedCloud Holdings$0.0827+8.67%
- NUNu Holdings$12.59−16.95%
- EWZiShares MSCI Brazil ETF$34.15−19.82%
- MDEXMadison Technologies$0.0002−33.33%
- BBDBanco Bradesco S.A.$2.93−28.01%
- MASNMaison Luxe$0.0002+0.00%
- LTNCLabor Smart$0.0001+0.00%
- TGLTreasure Global$0.2427+9.57%
- AZTRAzitra$1.53
- ITUBItau Unibanco Holding S.A.$7.70−20.37%
Newly listed
Companies that went public in the past six weeks
- LYCALycia Therapeutics$28.85−3.83%
- DAVIDAVION HEALTHCARE$4.07−32.17%
- TCXBTCGX Acquisition Corp. II$10.27−2.10%
- CTYCITY THERAPEUTICS$20.79+0.10%
- IAMIambic Therapeutics$14.41+1.05%
- AMROAmaero$5.37−8.05%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.19%
- TRXBTRex Bio$13.87+0.43%
- RTSNRetension Pharmaceuticals$14.24−6.62%
- PAXGUPine Tree Acquisition$10.02+0.15%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13+0.10%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.